BioSpace News Archive

Competition was developed to encourage intersection of IT with life sciences research on two Hoosier health issues - diabetes and opioid addiction

A three-member JAMS panel issued an Interim Award in the arbitration between Intellia Therapeutics, Inc. and Caribou Biosciences, Inc.

Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics.

Sysmex America, Inc. and LabCorp® (NYSE: LH) announced an extension of their hematology automation agreement, to provide LabCorp Diagnostics’ primary reference laboratories with Sysmex America’s latest, upgraded XN-Series technology.

Former CEO of Philips’ Personal Health Business Will Now Help the Company Behind the Groundbreaking CPAP Cleaner Advance Its Mission to Improve the Lives of Sleep Apnea Sufferers in Europe and Asia

The Prostate Cancer Foundation (PCF) today announced a collaboration with Pfizer Global Medical Grants to fund approximately $2 million in research grants through a Competitive Research Grants Program, which is focused on investigating talazoparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in prostate cancer

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that the Company has reached a one-year milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™). The stability study was conducted in strict compliance with FDA/ICH guidelines (Q1A-R2).

American Cancer Society and GameChanger Charity Announce New Initiative

The conference is being held at the Intercontinental New York Barclay Hotel.

Nurx, the health tech company focused on sensitive health needs and the leading online provider for contraception, today announced a partnership with Power to Decide, the campaign to prevent unplanned pregnancy.